Endocrine Disrupting Chemical
New international group advocates for endocrine-disrupting chemical research, legislation
European strategy aims to rein in EDC exposures
Adolescent exposure to endocrine-disrupting chemicals linked to ADHD-related behaviors
High BPA exposure may increase all-cause mortality
Growing evidence shows endocrine-disrupting chemicals drive obesity, infertility, diabetes
Phthalates may contribute to sleep disruption in menopause
Effects of endocrine-disrupting chemicals extend to obesity, osteoporosis, IQ and beyond
Phthalates from plastics, personal care products influence testosterone levels among men
VIDEO: Exposure to common chemicals may lead to obesity, diabetes
In this video exclusive, Abby Fleisch, MD, MPH, attending physician in pediatric endocrinology and diabetes at the Center for Outcomes Research and Evaluation at Maine Medical Center, describes how exposure to common perfluoroalkyl and polyfluoroalkyl substances — better known as the endocrine-disrupting chemicals PFAS — is associated with obesity, diabetes and high cholesterol levels.
Experts warn PFAS endocrine-disrupting chemicals may drive obesity, osteoporosis
WASHINGTON — A class of endocrine-disrupting chemicals known as PFAS may work as an “environmental trigger” to drive multiple adverse endocrine health effects, including obesity, thyroid dysfunction and low bone mineral density, although researchers caution that more studies on potential associations are needed.